山东威智百科药业有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
109
NMPA:109
Drug Approvals
Nitroglycerin Sublingual Tablets
- Product Name
- 硝酸甘油舌下片
- Approval Number
- 国药准字H20253628
- Approval Date
- Mar 18, 2025
NMPA
Nitroglycerin Sublingual Tablets
- Product Name
- 硝酸甘油舌下片
- Approval Number
- 国药准字H20253627
- Approval Date
- Mar 18, 2025
NMPA
Nitroglycerin Sublingual Tablets
- Product Name
- 硝酸甘油舌下片
- Approval Number
- 国药准字H20253612
- Approval Date
- Mar 11, 2025
NMPA
Phenylephrine Hydrochloride Injection
- Product Name
- 盐酸去氧肾上腺素注射液
- Approval Number
- 国药准字H20249727
- Approval Date
- Dec 10, 2024
NMPA
Brimonidine Tartrate and Timolol Maleate Eye Drops
- Product Name
- 溴莫尼定噻吗洛尔滴眼液
- Approval Number
- 国药准字H20249650
- Approval Date
- Dec 1, 2024
NMPA
Gadoteric Acid Meglumine Salt Injection
- Product Name
- 钆特酸葡胺注射液
- Approval Number
- 国药准字H20243900
- Approval Date
- Jun 4, 2024
NMPA
Gadoteric Acid Meglumine Salt Injection
- Product Name
- 钆特酸葡胺注射液
- Approval Number
- 国药准字H20243901
- Approval Date
- Jun 4, 2024
NMPA
Gadoteric Acid Meglumine Salt Injection
- Product Name
- 钆特酸葡胺注射液
- Approval Number
- 国药准字H20243899
- Approval Date
- Jun 4, 2024
NMPA
Brimonidine Tartrate Eye Drops
- Product Name
- 酒石酸溴莫尼定滴眼液
- Approval Number
- 国药准字H20243347
- Approval Date
- Mar 19, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 11
- Next
Clinical Trials
No trials found
News
No news found